NCT00741117

Brief Summary

The purpose of this study is to determine if higher levels of bilirubin in the blood of people with liver disease affects how accurate a pulse oximeter machine is able to measure the concentration of oxygen in the blood. Previous studies have reported conflicting results regarding the affect of high levels of bilirubin in the blood on the accuracy of the pulse oximeter reading. Initial studies showed an underestimation of the oxygen concentration in the presence of elevated bilirubin. Subsequent studies have suggested that high levels of bilirubin in the blood do not influence the accuracy of the pulse oximeter machine. However, recent reports in bone marrow transplant literature and our personal observations in patients with liver disease suggest that high bilirubin levels are associated with an overestimation of the oxygen concentration as measured by the pulse oximeter machine.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2011

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 26, 2008

Completed
3.1 years until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
Last Updated

March 6, 2013

Status Verified

March 1, 2013

Enrollment Period

Same day

First QC Date

August 25, 2008

Last Update Submit

March 5, 2013

Conditions

Keywords

Pulse OximetryBlood Gas AnalysisLiver DiseaseHyperbilirubinemia

Outcome Measures

Primary Outcomes (1)

  • Comparison of pulse oximetric saturation and calculated oxygen saturation.

    Enrollment visit

Study Arms (3)

Low Bilirubin Group

ACTIVE COMPARATOR

Low Bilirubin Group: subjects with a bilirubin level less than or equal to 10 mg/dl

Procedure: Arterial Blood GasProcedure: Pulse Oximetry MachineProcedure: Direct and Indirect Serum Bilirubin Measurement

Medium Bilirubin Group

ACTIVE COMPARATOR

Medium Bilirubin Group: subjects with a bilirubin level from 11mg/dl to 30 mg/dl

Procedure: Arterial Blood GasProcedure: Pulse Oximetry MachineProcedure: Direct and Indirect Serum Bilirubin Measurement

High Bilirubin Group

ACTIVE COMPARATOR

High Bilirubin Group: subjects with a bilirubin level greater than or equal to 30 mg/dl

Procedure: Arterial Blood GasProcedure: Pulse Oximetry MachineProcedure: Direct and Indirect Serum Bilirubin Measurement

Interventions

One blood gas sample will be obtained from an artery in the arm.

Also known as: ABG
High Bilirubin GroupLow Bilirubin GroupMedium Bilirubin Group

A pulse oximetry machine will be used at one time point to obtain an oxygen saturation reading. This is done by placing a clip onto the finger. The pulse oximetry value displays on the pulse oximeter machine within seconds.

Also known as: Pulse Ox
High Bilirubin GroupLow Bilirubin GroupMedium Bilirubin Group

One tube of blood will be drawn from a vein in the arm at one timepoint to measure the direct and indirect serum bilirubin levels.

Also known as: hepatic function panel
High Bilirubin GroupLow Bilirubin GroupMedium Bilirubin Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with established liver disease or dysfunction, as determined by abnormal liver function tests, imaging, or biopsy

You may not qualify if:

  • Patients with unconjugated hyperbilirubinemia, which could be associated with elevations in carboxyhemoglobin
  • Patients with poor peripheral perfusion that would compromise accurate pulse oximetric determination

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory University Hospital

Atlanta, Georgia, 30322, United States

Location

Related Publications (6)

  • Staudinger T, Locker GJ, Frass M, Kalhs P. Misleading high values of oxygen saturation measured by pulse oximetry in excessive hyperbilirubinaemia after BMT. Bone Marrow Transplant. 1996 Nov;18(5):1025. No abstract available.

    PMID: 8932862BACKGROUND
  • Veyckemans F, Baele P, Guillaume JE, Willems E, Robert A, Clerbaux T. Hyperbilirubinemia does not interfere with hemoglobin saturation measured by pulse oximetry. Anesthesiology. 1989 Jan;70(1):118-22. doi: 10.1097/00000542-198901000-00022.

    PMID: 2912292BACKGROUND
  • Ramanathan R, Durand M, Larrazabal C. Pulse oximetry in very low birth weight infants with acute and chronic lung disease. Pediatrics. 1987 Apr;79(4):612-7.

    PMID: 2434913BACKGROUND
  • Praud JP, Carofilis A, Bridey F, Lacaille F, Dehan M, Gaultier CL. Accuracy of two wavelength pulse oximetry in neonates and infants. Pediatr Pulmonol. 1989;6(3):180-2. doi: 10.1002/ppul.1950060310.

    PMID: 2470014BACKGROUND
  • Ralston AC, Webb RK, Runciman WB. Potential errors in pulse oximetry. III: Effects of interferences, dyes, dyshaemoglobins and other pigments. Anaesthesia. 1991 Apr;46(4):291-5. doi: 10.1111/j.1365-2044.1991.tb11501.x.

    PMID: 2024749BACKGROUND
  • Amazon K, Soloni F, Rywlin AM. Separation of bilirubin from hemoglobin by recording derivative spectrophotometry. Am J Clin Pathol. 1981 Apr;75(4):519-23. doi: 10.1093/ajcp/75.4.519.

    PMID: 7223716BACKGROUND

MeSH Terms

Conditions

Liver DiseasesHyperbilirubinemia

Interventions

Blood Gas AnalysisOximetry

Condition Hierarchy (Ancestors)

Digestive System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemInvestigative TechniquesHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Ram Subramanian, MD

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. Department of Medicine, Hepatology

Study Record Dates

First Submitted

August 25, 2008

First Posted

August 26, 2008

Study Start

October 1, 2011

Primary Completion

October 1, 2011

Study Completion

October 1, 2011

Last Updated

March 6, 2013

Record last verified: 2013-03

Locations